Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
BME Frontiers · 2024-01 · 5
DOI: 10.34133/bmef.0038 ↗Kurz gefasst
Fachartikel in der Zeitschrift BME Frontiers, online erschienen am 21.03.2024. Verfasst von Kefan Song und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Washington, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
With the recent advances in neoantigen identification, peptide-based cancer vaccines offer substantial potential in the field of immunotherapy. However, rapid clearance, low immunogenicity, and insufficient antigen-presenting cell (APC) uptake limit the efficacy of peptide-based cancer vaccines. This review explores the barriers hindering vaccine efficiency, highlights recent advancements in synthetic delivery systems, and features strategies for the key delivery steps of lymph node (LN) drainage, APC delivery, cross-presentation strategies, and adjuvant incorporation. This paper also discusses the design of preclinical studies evaluating vaccine efficiency, including vaccine administration routes and murine tumor models.
Autor:innen und Institutionen
- Department of Bioengineering, University of Washington, USA.
- Molecular Engineering & Sciences Institute, University of Washington, USA.
ORCID-Profile: Suzie H Pun
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Song, K., & Pun, S. H. (2024). Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines. BME Frontiers, 5. https://doi.org/10.34133/bmef.0038
Vancouver
Song K, Pun SH. Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines. BME Frontiers. 2024;5. doi:10.34133/bmef.0038
BibTeX
@article{Song2024,
author = {Song, Kefan and Pun, Suzie H},
title = {Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines},
journal = {BME Frontiers},
year = {2024},
volume = {5},
doi = {10.34133/bmef.0038}
}
EUVIMED